Literature DB >> 14479079

Disposal of human chylomicrons administered intravenously in ischemic heart disease and essential hyperlipemia.

P J NESTEL, M A DENBOROUGH, J O'DEA.   

Abstract

Entities:  

Keywords:  CORONARY VESSELS/metabolism; FATS/metabolism; LIPIDS/blood

Mesh：

Substances：

Year:  1962        PMID： 14479079     DOI： 10.1161/01.res.10.5.786

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  6 in total

1.  RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS.

Authors:  P J NESTEL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  [Studies on chylomicron metabolism. I. Intravenous radioactive-labelled chylomicron injections in normal and hyperlipemic persons].

Authors:  F A GRIES; G F JUNG; K JAHNKE
Journal:  Klin Wochenschr       Date:  1963-07-01

3.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.

Authors:  J D Brunzell; W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

4.  Lipid metabolism following triglyceride ingestion in intact and adrenalectomized rats.

Authors:  A I Fleischman; P H Lenz
Journal:  Lipids       Date:  1973-04       Impact factor: 1.880

5.  Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion.

Authors:  Y Park; B D Damron; J M Miles; W S Harris
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

6.  Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.